mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.04 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |